NO20053876L - Carbonylamino-substituted acylphenylurea derivatives, process for their preparation and use thereof - Google Patents
Carbonylamino-substituted acylphenylurea derivatives, process for their preparation and use thereofInfo
- Publication number
- NO20053876L NO20053876L NO20053876A NO20053876A NO20053876L NO 20053876 L NO20053876 L NO 20053876L NO 20053876 A NO20053876 A NO 20053876A NO 20053876 A NO20053876 A NO 20053876A NO 20053876 L NO20053876 L NO 20053876L
- Authority
- NO
- Norway
- Prior art keywords
- carbonylamino
- substituted
- preparation
- acylphenylurea
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/48—Y being a hydrogen or a carbon atom
- C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Abstract
The invention relates to compounds of formula (I) wherein the radicals have the cited meaning, in addition to the physiologically compatible salts thereof. The compounds, for example, can be used as medicaments for preventing and treating type 2 diabetes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10302452A DE10302452B4 (en) | 2003-01-23 | 2003-01-23 | Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use |
PCT/EP2004/000041 WO2004065356A1 (en) | 2003-01-23 | 2004-01-07 | Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053876D0 NO20053876D0 (en) | 2005-08-18 |
NO20053876L true NO20053876L (en) | 2005-10-12 |
Family
ID=32694928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053876A NO20053876L (en) | 2003-01-23 | 2005-08-18 | Carbonylamino-substituted acylphenylurea derivatives, process for their preparation and use thereof |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1590322B1 (en) |
JP (1) | JP4557963B2 (en) |
KR (1) | KR20050104351A (en) |
CN (1) | CN1798730A (en) |
AT (1) | ATE443697T1 (en) |
AU (1) | AU2004205352A1 (en) |
BR (1) | BRPI0406840A (en) |
CA (1) | CA2513286A1 (en) |
CO (1) | CO5690542A2 (en) |
DE (2) | DE10302452B4 (en) |
HR (1) | HRP20050667A2 (en) |
MA (1) | MA27649A1 (en) |
MX (1) | MXPA05007515A (en) |
NO (1) | NO20053876L (en) |
PL (1) | PL376456A1 (en) |
RU (1) | RU2005126606A (en) |
WO (1) | WO2004065356A1 (en) |
ZA (1) | ZA200504647B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1865949B1 (en) * | 2005-03-11 | 2012-11-14 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
PE20080251A1 (en) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | USES OF DPP IV INHIBITORS |
WO2009081892A1 (en) * | 2007-12-25 | 2009-07-02 | Kissei Pharmaceutical Co., Ltd. | Novel catechol derivative, pharmaceutical composition containing the same, and use of those |
EP2543660A4 (en) * | 2010-03-04 | 2014-04-30 | Ajinomoto Kk | Prophylactic or therapeutic agent for diabetes or obesity |
GB201223308D0 (en) | 2012-12-21 | 2013-02-06 | Univ Sunderland | Enzyme inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH508019A (en) * | 1968-12-12 | 1971-05-31 | Ciba Geigy Ag | Process for the production of new azo dye pigments |
EP0116729B1 (en) * | 1983-01-24 | 1988-10-12 | Duphar International Research B.V | Benzoylurea compounds and pesticidal compositions comprisingsame |
ZA861446B (en) * | 1985-03-01 | 1986-10-29 | Duphar Int Res | Benzoyl urea derivatives having anti-tumor activity |
ZA89135B (en) * | 1988-01-11 | 1989-10-25 | Duphar Int Res | Method of treating hematologic diseases and pharmaceutical composition to be used therefor |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
AU2713699A (en) * | 1998-03-12 | 1999-09-27 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
RU2216541C2 (en) * | 1998-08-04 | 2003-11-20 | Астразенека Аб | Derivatives of benzamide, method for their preparing and pharmaceutical composition based on thereof |
GB0001662D0 (en) * | 1999-02-06 | 2000-03-15 | Zeneca Ltd | Pharmaceutical compositions |
EE200200634A (en) * | 2000-06-09 | 2004-04-15 | Aventis Pharma Deutschland Gmbh | Acylphenylurea derivatives, their preparation and their use in the preparation of a blood glucose lowering drug and a medicament containing them |
PE20021091A1 (en) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | DERIVATIVES OF PHENYLUREA SUBSTITUTED WITH CARBONAMIDE AND PROCEDURE FOR THEIR PREPARATION |
DE10225635C1 (en) * | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-benzoylureido-cinnamic acid derivatives, process for their preparation and their use |
-
2003
- 2003-01-23 DE DE10302452A patent/DE10302452B4/en not_active Expired - Fee Related
-
2004
- 2004-01-07 CN CNA200480002674XA patent/CN1798730A/en active Pending
- 2004-01-07 EP EP04700448A patent/EP1590322B1/en not_active Expired - Lifetime
- 2004-01-07 JP JP2006500523A patent/JP4557963B2/en not_active Expired - Fee Related
- 2004-01-07 DE DE502004010108T patent/DE502004010108D1/en not_active Expired - Lifetime
- 2004-01-07 WO PCT/EP2004/000041 patent/WO2004065356A1/en active Application Filing
- 2004-01-07 PL PL04376456A patent/PL376456A1/en not_active Application Discontinuation
- 2004-01-07 AU AU2004205352A patent/AU2004205352A1/en not_active Abandoned
- 2004-01-07 CA CA002513286A patent/CA2513286A1/en not_active Abandoned
- 2004-01-07 KR KR1020057013500A patent/KR20050104351A/en not_active Application Discontinuation
- 2004-01-07 MX MXPA05007515A patent/MXPA05007515A/en not_active Application Discontinuation
- 2004-01-07 RU RU2005126606/04A patent/RU2005126606A/en not_active Application Discontinuation
- 2004-01-07 AT AT04700448T patent/ATE443697T1/en not_active IP Right Cessation
- 2004-01-07 BR BR0406840-8A patent/BRPI0406840A/en not_active IP Right Cessation
-
2005
- 2005-06-07 ZA ZA200504647A patent/ZA200504647B/en unknown
- 2005-07-21 CO CO05071890A patent/CO5690542A2/en not_active Application Discontinuation
- 2005-07-22 HR HR20050667A patent/HRP20050667A2/en not_active Application Discontinuation
- 2005-07-22 MA MA28408A patent/MA27649A1/en unknown
- 2005-08-18 NO NO20053876A patent/NO20053876L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200504647B (en) | 2006-04-26 |
CO5690542A2 (en) | 2006-10-31 |
JP4557963B2 (en) | 2010-10-06 |
BRPI0406840A (en) | 2005-12-13 |
RU2005126606A (en) | 2006-01-20 |
CN1798730A (en) | 2006-07-05 |
DE10302452B4 (en) | 2005-02-24 |
AU2004205352A1 (en) | 2004-08-05 |
EP1590322A1 (en) | 2005-11-02 |
EP1590322B1 (en) | 2009-09-23 |
CA2513286A1 (en) | 2004-08-05 |
ATE443697T1 (en) | 2009-10-15 |
WO2004065356A1 (en) | 2004-08-05 |
MA27649A1 (en) | 2005-12-01 |
DE502004010108D1 (en) | 2009-11-05 |
DE10302452A1 (en) | 2004-08-12 |
JP2006516971A (en) | 2006-07-13 |
MXPA05007515A (en) | 2006-01-27 |
NO20053876D0 (en) | 2005-08-18 |
PL376456A1 (en) | 2005-12-27 |
HRP20050667A2 (en) | 2006-09-30 |
KR20050104351A (en) | 2005-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
MX2007000505A (en) | Substituted oxindol derivatives and medicaments containing the same. | |
NO20053748L (en) | Pyrrolopyridazine derivatives. | |
TR200302242T2 (en) | Pyrolopyrimidines as protein kinase inhibitors | |
AP1614A (en) | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents. | |
NO20064201L (en) | Glucopyranosyl substituted benzene derivatives, drugs containing such compounds, their use and preparation | |
DE60236541D1 (en) | INHIBITORS OF 11-BETA-HYDROXYSTEROIDDEHYDROGENASE TYPE 1 | |
NO20055649L (en) | Substituted dihydroquinazoline with antivial properties | |
NO20056010L (en) | Biaryloksymetylaren acids | |
TW200615266A (en) | Organic compounds | |
BRPI0307351B8 (en) | compound, pharmaceutical composition, use of a compound, and, process for preparing a compound | |
BR0113838A (en) | N-phenyl-2-pyrimidine amine derivatives | |
NO20050088L (en) | Cationically substituted diphenylazofidinones, processes for their preparation, medicaments containing said compounds, and use thereof | |
BR0307291A (en) | Compound; process for the preparation of a compound; pharmaceutical composition; use of a compound; method for the treatment and prophylaxis of various disorders and obesity in a human | |
BR0309343A (en) | Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions. | |
MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
NO20063865L (en) | Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments | |
NO20063619L (en) | Diarylmethylpiperazine derivatives, preparation and use thereof | |
SE0301701D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
MXPA04001256A (en) | Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof. | |
NO20053876D0 (en) | Carbonylamino-substituted acylphenylurea derivatives, process for their preparation and use thereof | |
SE0301699D0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
TW200609222A (en) | Diazole derivatives | |
TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
NO20053805L (en) | Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |